+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Johnson & Johnson Services, Inc. - logo

Johnson & Johnson has more than 250 companies located in 60 countries around the world. Their companies are broken down into several business segments: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson’s consumer healthcare segment produces a variety of consumer care products in the areas of baby care, skin and hair care, wound care, oral health, OTC medicines and nutritionals. Their medical devices segment produces a broad range of products used by healthcare professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, cardiovascular disease, sports medicine, and aesthetics. The Janssen Pharmaceutical Companies of Johnson & Johnson are focused on oncology, immunology, neuroscience and infectious diseases, as well as cardiovascular and metabolic diseases. Their company headquarters are based in New Brunswick, New Jersey, USA.

Hair Heat Protectants Market - Global Forecast 2025-2032 - Product Thumbnail Image

Hair Heat Protectants Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 194 Pages
  • Global
From
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 409 Pages
  • Global
From
Catecholamines - Global Strategic Business Report - Product Thumbnail Image

Catecholamines - Global Strategic Business Report

  • Report
  • February 2026
  • 372 Pages
  • Global
From
Spinal Pumps Market - Global Strategic Business Report - Product Thumbnail Image

Spinal Pumps Market - Global Strategic Business Report

  • Report
  • February 2026
  • 366 Pages
  • Global
From
Blarcamesine Market - Global Strategic Business Report - Product Thumbnail Image

Blarcamesine Market - Global Strategic Business Report

  • Report
  • February 2026
  • 370 Pages
  • Global
From
From
From
Cerebral Infarction Treatment - Global Strategic Business Report - Product Thumbnail Image

Cerebral Infarction Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 372 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 276 Pages
  • Global
From
Dementia Treatment - Global Strategic Business Report - Product Thumbnail Image

Dementia Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 204 Pages
  • Global
From
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • February 2026
  • 367 Pages
  • Global
From
Anticholinergic Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 276 Pages
  • Global
From
Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 276 Pages
  • Global
From
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 193 Pages
  • Global
From
Insomnia Drugs - Global Strategic Business Report - Product Thumbnail Image

Insomnia Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 189 Pages
  • Global
From
Loading Indicator